Melt Pharmaceuticals, Inc. (MELT)

Melt Pharmaceuticals was planning to go public, but the IPO was withdrawn on Jan 4, 2023.

Stock Price: Pending

IPO price not available yet

Melt Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-10.24	-6.65	-4.54
Depreciation & Amortization	0.03	0.01	0
Share-Based Compensation	-	0.58	0.4
Other Operating Activities	2.93	1.84	-0.35
Operating Cash Flow	-7.28	-4.23	-4.49
Debt Issued / Paid	-	12.55	-
Financing Cash Flow	12.55	12.55	-
Net Cash Flow	5.28	8.33	-4.49
Free Cash Flow	-7.28	-4.23	-4.49

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).